Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, an androgen receptor blocker, significantly increased hair density, thickness, and length in monkeys when applied topically daily for several months.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Finasteride may effectively reduce Tourette's syndrome symptoms and improve life quality.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

Combined minoxidil and PRP therapy improves hair growth without affecting physical performance.

Haloperidol effectively treated hemiballismus, but spontaneous improvement wasn't ruled out; rapid weight loss can cause hair loss with good regrowth chances.

Allopregnanolone may help prevent nicotine withdrawal symptoms.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

PRP injections are safe but don't significantly improve Peyronie's Disease.

Neurosteroids may help metyrapone reduce cocaine addiction.